• Data from a multi-state hospital system included all tPA-treated patients discharged between January 2011 and May 2018.
• Patients who were <18 years old, received thrombectomy, transferred to another hospital, or had an inpatient stroke were excluded. • Outcomes included percentage of patients who experienced any complication, sICH, life-threatening systemic hemorrhage, other serious complication, or inhospital mortality or discharge to hospice. • Chi-squared and Fisher's exact tests and generalized linear models were used to compare outcomes between patients with MIS (NIHSS≤5) and moderateto-severe strokes (NIHSS>5).
• Risk of complication versus potential benefit is considered when deciding whether to treat acute ischemic stroke with IV alteplase (tPA).
• Symptomatic intracerebral hemorrhage (sICH) rate is often quoted as 6.4% based on the NINDS trials.
• sICH risk often makes patients and physicians wary of tPA treatment for mild ischemic stroke (MIS) 1 .
• 2018 ASA guidelines removed MIS as a relative contraindication to tPA 2 .
• A few small studies have revealed mixed outcomes and treatment complications in MIS 2,3 .
• This study compared tPA-related complications in MIS vs. moderate-to-severe stroke in a large hospital system.
• Complications from tPA, including sICH and in-hospital mortality or discharge to hospice, were less frequent than in the NINDS studies.
• Complications from tPA in MIS were less frequent than moderate-to-severe stroke.
• Our data suggests that tPA treatment poses minimal risk in MIS.
• A total of 3,087 patients met inclusion criteria, of these 36.0% (1,111) had a mild stroke.
• MIS patients were less likely than moderate-to-severe stroke patients to have sICH (1.3% vs. 4.4%; p<0.001), lifethreatening systemic hemorrhage (0% vs. 0.8%; p<0.001), or other serious complications (0.5% vs. 2.1%; p<0.001) (Figure 1 ). • In multivariate analysis, patients with MIS were 73% (95% CI: 56, 83; p<0.001) less likely than those with moderate-to-severe stroke to have any complication and 87% (95% CI: 79, 92; p<0.001) less likely to die or discharge to hospice after adjusting for age, sex, hospital, and history of atrial fibrillation, hypertension, diabetes, and coronary artery disease or prior myocardial infarction (Figure 2 ). 
